Lupin Pharmaceuticals Inc. recalls Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls 150mg Rifampin capsules due to impurity detected in manufacturing. This may affect safety for patients using prescription medication. Contact for details.
Recall notice
CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
Contact the company & request your remedy
What happened, in plain English
Lupin Pharmaceuticals is recalling 150mg Rifampin capsules because a chemical impurity was found during manufacturing. This could pose a safety risk for patients taking the medication as prescribed. Read more at govinfonow.com/recall/34387-lupin-rifampin-capsules-recall-impurity-risk-in-150mg-dose.
Source Summary by GovInfoNow · govinfonow.com/recall/34387-lupin-rifampin-capsules-recall-impurity-risk-in-150mg-dose · Updated September 23, 2026 · FDA enforcement record: FDA #D-1343-2022
Cite this page
“Lupin Rifampin Capsules Recall: Impurity Risk in 150mg Dose.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34387-lupin-rifampin-capsules-recall-impurity-risk-in-150mg-dose. Based on FDA recall #D-1343-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1343-2022%22&limit=1).
Why it’s dangerous
The recall involves a chemical impurity (1-Methyl-4-Nitroso Piperazine) detected in the manufacturing process. This impurity could potentially affect the safety of the medication when taken by patients. The exact health risk is not specified in the recall notice.
Who’s affected
Patients prescribed Rifampin capsules by a healthcare provider are affected. Those using the medication for conditions like tuberculosis or liver disease may be at higher risk.
How to tell if you have this one
Check for Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles with NDC 68180-658-06 and Lot #A200170, expiring December 2023. The product is prescription-only and manufactured by Lupin Pharmaceuticals in Baltimore, MD.
- Brand
Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Verify if your Rifampin capsules match the NDC 68180-658-06 and Lot #A200170 with expiration December 2023.
Questions people ask
Is this product safe to use?
The recall notice states a chemical impurity was found but does not specify if the product is safe to use. Consult your healthcare provider for guidance.
How can I get a replacement?
The recall notice does not mention a replacement or remedy process.
What should I do if I have the recalled product?
The recall notice does not specify actions for affected individuals beyond checking product details.
Contact Lupin Pharmaceuticals
We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1343-2022 — Lupin Pharmaceuticals Lupin Pharmaceuticals Hello, I own a Lupin Pharmaceuticals that is covered by recall D-1343-2022 from Lupin Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1343-2022 (July 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1343-2022 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.